Intermittent claudication (IC) in peripheral vascular disease is characterized by lower limb pain appearing on effort. Treatment with PGE1 has been successfully used to manage IC patients. This registry has evaluated safety and costs of PGE1 in the management of IC.
|Titolo:||[Severe intermittent claudication: PGE1 treatment. A 40-week registry, efficacy and costs]|
|Parole Chiave:||aged; alprostadil; analysis of variance; cost-benefit analysis; exercise test; female; follow-up studies; humans; intermittent claudication; Italy; male; middle aged; risk assessment; risk factors; severity of illness index; time factors; treatment outcome; vasodilator agents|
|Settore Scientifico Disciplinare:||Settore MED/22 - Chirurgia Vascolare|
|Data di pubblicazione:||ago-2012|
|Appare nelle tipologie:||01 - Articolo su periodico|